Actual Medicinal Product (AMP) Demeclocycline 150mg capsules (Dawa Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from light. Protect from moisture. Manufacturer recommends storing in original container.
No stability data in MCAs available. - Provenance
-
This recommendation is based on the products demeclocycline 150mg capsules (ADVANZ Pharma) and demeclocycline 150mg and 300mg capsules (Dawa Limited).
- Generic
- Demeclocycline
- Formulation
- Demeclocycline 150mg capsules
-
Demeclocycline
-
Demeclocycline 150mg capsules
-
Demeclocycline 150mg capsules (Dawa Ltd)
-
-